Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
50
-
Total 13F shares, excl. options
-
11.4M
-
Shares change
-
+246K
-
Total reported value, excl. options
-
$16.2M
-
Value change
-
+$339K
-
Number of buys
-
20
-
Number of sells
-
-12
-
Price
-
$1.43
Significant Holders of Niagen Bioscience, Inc. - COM NEW (NAGE) as of Q4 2023
58 filings reported holding NAGE - Niagen Bioscience, Inc. - COM NEW as of Q4 2023.
Niagen Bioscience, Inc. - COM NEW (NAGE) has 50 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.4M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (3.05M shares), Tieton Capital Management, LLC (2.91M shares), ICONIQ Capital, LLC (1.3M shares), BlackRock Inc. (905K shares), GEODE CAPITAL MANAGEMENT, LLC (504K shares), RENAISSANCE TECHNOLOGIES LLC (469K shares), GAMCO INVESTORS, INC. ET AL (262K shares), GABELLI FUNDS LLC (200K shares), STATE STREET CORP (190K shares), and CITADEL ADVISORS LLC (180K shares).
This table shows the top 50 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.